Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Complex treatment of anal fistulas with extensive inflammatory infiltration

Breadcrumb

  • Home
  • Complex treatment of anal fistulas with extensive inflammatory infiltration

Guangcan Chen LI 1, Lo YAU 2, Qi Hao HOU 1, Yanting LOU 3, Denis Mak CHI 2, * and Marek Y. NITSETSKYI 3

1 Weihai Municipal Hospital, Weihai, Shandong, China.
2 Weihaiwei People's Hospital, Weihai, Shandong, China.
3 Weihai Qiaotou Hospital, Weihai, Shandong, China.
 

Research Article
 
World Journal of Biology Pharmacy and Health Sciences, 2021, 06(01), 070-076.
Article DOI: 10.30574/wjbphs.2021.6.1.0039
DOI url: https://doi.org/10.30574/wjbphs.2021.6.1.0039

Received on 21 March 2021; revised on 24 April 2021; accepted on 29 April 2021

Background: Anal fistulas with extensive inflammatory infiltration pose significant challenges in treatment, often leading to prolonged hospital stays, complications, and reduced quality of life. This study evaluates the efficacy of rectal suppositories containing streptokinase (15,000 IU) and streptodornase (1,250 IU) as an adjunct to standard therapy, including assessment of inflammatory cytokines.
Methods: A prospective randomized controlled trial was conducted from September 2018 to December 2019 at Weihaiwei People's Hospital. Sixty patients with anal fistulas and extensive inflammatory infiltration were divided into two groups: Group 1 (n=30) received standard treatment per international guidelines, while Group 2 (n=30) received the same plus rectal suppositories. Suppositories were administered based on disease severity: for severe cases, 1 suppository three times daily for 3 days, twice daily for 3 days, and once daily for 3 days; for moderate/mild cases, twice daily for 3 days, then once daily for 4 days or twice daily for 2 days. Outcomes included hospital stay duration, severe disease incidence, complications, pain syndrome (via Visual Analog Scale, VAS), quality of life (QoLAF-Q), and serum levels of TNF-α and IL-1β.
Results: Group 2 showed significantly shorter hospital stays (mean 18.5 ± 4.3 days vs. 12.5 ± 2.9 days, p<0.001), fewer severe cases (37% vs. 13%, p<0.01), fewer complications (27% vs. 10%, p<0.05), lower VAS scores, improved QoLAF-Q scores, and reduced serum TNF-α and IL-1β levels compared to Group 1. Significant positive correlations were observed between TNF-α, IL-1β, VAS, and QoLAF-Q.
Conclusions: Adjunctive enzymatic (streptokinase-streptodornase suppositories) therapy in complex treatment of anal fistulas with extensive inflammatory infiltration demonstrates notable benefits including shortened hospitalization periods, decreased complication rates, reduced pain levels, lowered cytokine concentrations, and enhanced quality of life when compared to conventional treatment alone.
 

Anal fistula; Inflammatory infiltration; Streptokinase; Streptodornase; Rectal suppositories; Quality of life; TNF-α; IL-1β

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2021-0039.pdf

Get Your e Certificate of Publication using below link

Download Certificate

Preview Article PDF

Guangcan Chen LI, Lo YAU, Qi Hao HOU, Yanting LOU, Denis Mak CHI and Marek Y. NITSETSKYI. Complex treatment of anal fistulas with extensive inflammatory infiltration. World Journal of Biology Pharmacy and Health Sciences, 2021, 06(01), 070-076. Article DOI: https://doi.org/10.30574/wjbphs.2021.6.1.0039

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution